The documented involvement of cholinergic dysfunction in neurodegenerative diseases [11], combined with the widespread use of cholinesterase inhibitors as a treatment for mild cognitive impairment, Alzheimer disease, and related dementias [24], highlights the essential role of acetylcholine as a therapeutic target to preserve the neurochemical integrity of the brain. This evidence concerns the gene BCHE and Cognitive impairment.